Global Hyperimmune Globulin Product Market Growth 2025-2031--LP INFORMATION, INC.

Global Hyperimmune Globulin Product Market Growth 2025-2031

Product Code: 1466047

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 119

Delivery Time: 2-3 business days

Global Hyperimmune Globulin Product Market Growth 2025-2031

Product Code: 1466047

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 119

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Hyperimmune Globulin Product market size is predicted to grow from US$ 2283 million in 2025 to US$ 3362 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Hyperimmune Globulin is a highly concentrated immunoglobulin containing high levels of specific antibodies used for passive immunotherapy. It is usually extracted from the plasma of recovered patients who have been infected with a specific pathogen, so these people have produced high levels of antibodies against the pathogen.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.

LP Information, Inc. (LPI) ' newest research report, the “Hyperimmune Globulin Product Industry Forecast” looks at past sales and reviews total world Hyperimmune Globulin Product sales in 2024, providing a comprehensive analysis by region and market sector of projected Hyperimmune Globulin Product sales for 2025 through 2031. With Hyperimmune Globulin Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Globulin Product industry.

This Insight Report provides a comprehensive analysis of the global Hyperimmune Globulin Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Globulin Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hyperimmune Globulin Product market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Globulin Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Globulin Product.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulin Product market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Hepatitis B Immuneglobulins

    Rabies Immuneglobulins

    Tetanus Toxin Immuneglobulins

    Rho(D) Immune Globulin

    Cytomegalovirus Immune Globulin

    Varicella-Zoster Immune Globulin

    Others

Segmentation by Application:

    Government Institution

    Private Sector

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    CSL Behring

    Grifols

    Biotest

    Kedrion

    Emergent

    Kamada

    CNBG

    Hualan Bio

    Shanghai RAAS

    CBPO

    Sichuan Yuanda Shuyang

    ADMA Biologics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hyperimmune Globulin Product market?

What factors are driving Hyperimmune Globulin Product market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hyperimmune Globulin Product market opportunities vary by end market size?

How does Hyperimmune Globulin Product break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Hyperimmune Globulin Product Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Hyperimmune Globulin Product by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Hyperimmune Globulin Product by Country/Region, 2020, 2024 & 2031
    2.2 Hyperimmune Globulin Product Segment by Type
        2.2.1 Hepatitis B Immuneglobulins
        2.2.2 Rabies Immuneglobulins
        2.2.3 Tetanus Toxin Immuneglobulins
        2.2.4 Rho(D) Immune Globulin
        2.2.5 Cytomegalovirus Immune Globulin
        2.2.6 Varicella-Zoster Immune Globulin
        2.2.7 Others
    2.3 Hyperimmune Globulin Product Sales by Type
        2.3.1 Global Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
        2.3.2 Global Hyperimmune Globulin Product Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Hyperimmune Globulin Product Sale Price by Type (2020-2025)
    2.4 Hyperimmune Globulin Product Segment by Application
        2.4.1 Government Institution
        2.4.2 Private Sector
        2.4.3 Others
    2.5 Hyperimmune Globulin Product Sales by Application
        2.5.1 Global Hyperimmune Globulin Product Sale Market Share by Application (2020-2025)
        2.5.2 Global Hyperimmune Globulin Product Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Hyperimmune Globulin Product Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Hyperimmune Globulin Product Breakdown Data by Company
        3.1.1 Global Hyperimmune Globulin Product Annual Sales by Company (2020-2025)
        3.1.2 Global Hyperimmune Globulin Product Sales Market Share by Company (2020-2025)
    3.2 Global Hyperimmune Globulin Product Annual Revenue by Company (2020-2025)
        3.2.1 Global Hyperimmune Globulin Product Revenue by Company (2020-2025)
        3.2.2 Global Hyperimmune Globulin Product Revenue Market Share by Company (2020-2025)
    3.3 Global Hyperimmune Globulin Product Sale Price by Company
    3.4 Key Manufacturers Hyperimmune Globulin Product Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Hyperimmune Globulin Product Product Location Distribution
        3.4.2 Players Hyperimmune Globulin Product Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Hyperimmune Globulin Product by Geographic Region
    4.1 World Historic Hyperimmune Globulin Product Market Size by Geographic Region (2020-2025)
        4.1.1 Global Hyperimmune Globulin Product Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Hyperimmune Globulin Product Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Hyperimmune Globulin Product Market Size by Country/Region (2020-2025)
        4.2.1 Global Hyperimmune Globulin Product Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Hyperimmune Globulin Product Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Hyperimmune Globulin Product Sales Growth
    4.4 APAC Hyperimmune Globulin Product Sales Growth
    4.5 Europe Hyperimmune Globulin Product Sales Growth
    4.6 Middle East & Africa Hyperimmune Globulin Product Sales Growth

5 Americas
    5.1 Americas Hyperimmune Globulin Product Sales by Country
        5.1.1 Americas Hyperimmune Globulin Product Sales by Country (2020-2025)
        5.1.2 Americas Hyperimmune Globulin Product Revenue by Country (2020-2025)
    5.2 Americas Hyperimmune Globulin Product Sales by Type (2020-2025)
    5.3 Americas Hyperimmune Globulin Product Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Hyperimmune Globulin Product Sales by Region
        6.1.1 APAC Hyperimmune Globulin Product Sales by Region (2020-2025)
        6.1.2 APAC Hyperimmune Globulin Product Revenue by Region (2020-2025)
    6.2 APAC Hyperimmune Globulin Product Sales by Type (2020-2025)
    6.3 APAC Hyperimmune Globulin Product Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Hyperimmune Globulin Product by Country
        7.1.1 Europe Hyperimmune Globulin Product Sales by Country (2020-2025)
        7.1.2 Europe Hyperimmune Globulin Product Revenue by Country (2020-2025)
    7.2 Europe Hyperimmune Globulin Product Sales by Type (2020-2025)
    7.3 Europe Hyperimmune Globulin Product Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Hyperimmune Globulin Product by Country
        8.1.1 Middle East & Africa Hyperimmune Globulin Product Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Hyperimmune Globulin Product Revenue by Country (2020-2025)
    8.2 Middle East & Africa Hyperimmune Globulin Product Sales by Type (2020-2025)
    8.3 Middle East & Africa Hyperimmune Globulin Product Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Hyperimmune Globulin Product
    10.3 Manufacturing Process Analysis of Hyperimmune Globulin Product
    10.4 Industry Chain Structure of Hyperimmune Globulin Product

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Hyperimmune Globulin Product Distributors
    11.3 Hyperimmune Globulin Product Customer

12 World Forecast Review for Hyperimmune Globulin Product by Geographic Region
    12.1 Global Hyperimmune Globulin Product Market Size Forecast by Region
        12.1.1 Global Hyperimmune Globulin Product Forecast by Region (2026-2031)
        12.1.2 Global Hyperimmune Globulin Product Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Hyperimmune Globulin Product Forecast by Type (2026-2031)
    12.7 Global Hyperimmune Globulin Product Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 CSL Behring
        13.1.1 CSL Behring Company Information
        13.1.2 CSL Behring Hyperimmune Globulin Product Product Portfolios and Specifications
        13.1.3 CSL Behring Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 CSL Behring Main Business Overview
        13.1.5 CSL Behring Latest Developments
    13.2 Grifols
        13.2.1 Grifols Company Information
        13.2.2 Grifols Hyperimmune Globulin Product Product Portfolios and Specifications
        13.2.3 Grifols Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Grifols Main Business Overview
        13.2.5 Grifols Latest Developments
    13.3 Biotest
        13.3.1 Biotest Company Information
        13.3.2 Biotest Hyperimmune Globulin Product Product Portfolios and Specifications
        13.3.3 Biotest Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Biotest Main Business Overview
        13.3.5 Biotest Latest Developments
    13.4 Kedrion
        13.4.1 Kedrion Company Information
        13.4.2 Kedrion Hyperimmune Globulin Product Product Portfolios and Specifications
        13.4.3 Kedrion Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Kedrion Main Business Overview
        13.4.5 Kedrion Latest Developments
    13.5 Emergent
        13.5.1 Emergent Company Information
        13.5.2 Emergent Hyperimmune Globulin Product Product Portfolios and Specifications
        13.5.3 Emergent Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Emergent Main Business Overview
        13.5.5 Emergent Latest Developments
    13.6 Kamada
        13.6.1 Kamada Company Information
        13.6.2 Kamada Hyperimmune Globulin Product Product Portfolios and Specifications
        13.6.3 Kamada Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Kamada Main Business Overview
        13.6.5 Kamada Latest Developments
    13.7 CNBG
        13.7.1 CNBG Company Information
        13.7.2 CNBG Hyperimmune Globulin Product Product Portfolios and Specifications
        13.7.3 CNBG Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 CNBG Main Business Overview
        13.7.5 CNBG Latest Developments
    13.8 Hualan Bio
        13.8.1 Hualan Bio Company Information
        13.8.2 Hualan Bio Hyperimmune Globulin Product Product Portfolios and Specifications
        13.8.3 Hualan Bio Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Hualan Bio Main Business Overview
        13.8.5 Hualan Bio Latest Developments
    13.9 Shanghai RAAS
        13.9.1 Shanghai RAAS Company Information
        13.9.2 Shanghai RAAS Hyperimmune Globulin Product Product Portfolios and Specifications
        13.9.3 Shanghai RAAS Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Shanghai RAAS Main Business Overview
        13.9.5 Shanghai RAAS Latest Developments
    13.10 CBPO
        13.10.1 CBPO Company Information
        13.10.2 CBPO Hyperimmune Globulin Product Product Portfolios and Specifications
        13.10.3 CBPO Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 CBPO Main Business Overview
        13.10.5 CBPO Latest Developments
    13.11 Sichuan Yuanda Shuyang
        13.11.1 Sichuan Yuanda Shuyang Company Information
        13.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Product Portfolios and Specifications
        13.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Sichuan Yuanda Shuyang Main Business Overview
        13.11.5 Sichuan Yuanda Shuyang Latest Developments
    13.12 ADMA Biologics
        13.12.1 ADMA Biologics Company Information
        13.12.2 ADMA Biologics Hyperimmune Globulin Product Product Portfolios and Specifications
        13.12.3 ADMA Biologics Hyperimmune Globulin Product Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 ADMA Biologics Main Business Overview
        13.12.5 ADMA Biologics Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Hyperimmune Globulin Product Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Hyperimmune Globulin Product Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Hepatitis B Immuneglobulins
 Table 4. Major Players of Rabies Immuneglobulins
 Table 5. Major Players of Tetanus Toxin Immuneglobulins
 Table 6. Major Players of Rho(D) Immune Globulin
 Table 7. Major Players of Cytomegalovirus Immune Globulin
 Table 8. Major Players of Varicella-Zoster Immune Globulin
 Table 9. Major Players of Others
 Table 10. Global Hyperimmune Globulin Product Sales by Type (2020-2025) & (K Units)
 Table 11. Global Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
 Table 12. Global Hyperimmune Globulin Product Revenue by Type (2020-2025) & ($ million)
 Table 13. Global Hyperimmune Globulin Product Revenue Market Share by Type (2020-2025)
 Table 14. Global Hyperimmune Globulin Product Sale Price by Type (2020-2025) & (US$/Unit)
 Table 15. Global Hyperimmune Globulin Product Sale by Application (2020-2025) & (K Units)
 Table 16. Global Hyperimmune Globulin Product Sale Market Share by Application (2020-2025)
 Table 17. Global Hyperimmune Globulin Product Revenue by Application (2020-2025) & ($ million)
 Table 18. Global Hyperimmune Globulin Product Revenue Market Share by Application (2020-2025)
 Table 19. Global Hyperimmune Globulin Product Sale Price by Application (2020-2025) & (US$/Unit)
 Table 20. Global Hyperimmune Globulin Product Sales by Company (2020-2025) & (K Units)
 Table 21. Global Hyperimmune Globulin Product Sales Market Share by Company (2020-2025)
 Table 22. Global Hyperimmune Globulin Product Revenue by Company (2020-2025) & ($ millions)
 Table 23. Global Hyperimmune Globulin Product Revenue Market Share by Company (2020-2025)
 Table 24. Global Hyperimmune Globulin Product Sale Price by Company (2020-2025) & (US$/Unit)
 Table 25. Key Manufacturers Hyperimmune Globulin Product Producing Area Distribution and Sales Area
 Table 26. Players Hyperimmune Globulin Product Products Offered
 Table 27. Hyperimmune Globulin Product Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 28. New Products and Potential Entrants
 Table 29. Market M&A Activity & Strategy
 Table 30. Global Hyperimmune Globulin Product Sales by Geographic Region (2020-2025) & (K Units)
 Table 31. Global Hyperimmune Globulin Product Sales Market Share Geographic Region (2020-2025)
 Table 32. Global Hyperimmune Globulin Product Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 33. Global Hyperimmune Globulin Product Revenue Market Share by Geographic Region (2020-2025)
 Table 34. Global Hyperimmune Globulin Product Sales by Country/Region (2020-2025) & (K Units)
 Table 35. Global Hyperimmune Globulin Product Sales Market Share by Country/Region (2020-2025)
 Table 36. Global Hyperimmune Globulin Product Revenue by Country/Region (2020-2025) & ($ millions)
 Table 37. Global Hyperimmune Globulin Product Revenue Market Share by Country/Region (2020-2025)
 Table 38. Americas Hyperimmune Globulin Product Sales by Country (2020-2025) & (K Units)
 Table 39. Americas Hyperimmune Globulin Product Sales Market Share by Country (2020-2025)
 Table 40. Americas Hyperimmune Globulin Product Revenue by Country (2020-2025) & ($ millions)
 Table 41. Americas Hyperimmune Globulin Product Sales by Type (2020-2025) & (K Units)
 Table 42. Americas Hyperimmune Globulin Product Sales by Application (2020-2025) & (K Units)
 Table 43. APAC Hyperimmune Globulin Product Sales by Region (2020-2025) & (K Units)
 Table 44. APAC Hyperimmune Globulin Product Sales Market Share by Region (2020-2025)
 Table 45. APAC Hyperimmune Globulin Product Revenue by Region (2020-2025) & ($ millions)
 Table 46. APAC Hyperimmune Globulin Product Sales by Type (2020-2025) & (K Units)
 Table 47. APAC Hyperimmune Globulin Product Sales by Application (2020-2025) & (K Units)
 Table 48. Europe Hyperimmune Globulin Product Sales by Country (2020-2025) & (K Units)
 Table 49. Europe Hyperimmune Globulin Product Revenue by Country (2020-2025) & ($ millions)
 Table 50. Europe Hyperimmune Globulin Product Sales by Type (2020-2025) & (K Units)
 Table 51. Europe Hyperimmune Globulin Product Sales by Application (2020-2025) & (K Units)
 Table 52. Middle East & Africa Hyperimmune Globulin Product Sales by Country (2020-2025) & (K Units)
 Table 53. Middle East & Africa Hyperimmune Globulin Product Revenue Market Share by Country (2020-2025)
 Table 54. Middle East & Africa Hyperimmune Globulin Product Sales by Type (2020-2025) & (K Units)
 Table 55. Middle East & Africa Hyperimmune Globulin Product Sales by Application (2020-2025) & (K Units)
 Table 56. Key Market Drivers & Growth Opportunities of Hyperimmune Globulin Product
 Table 57. Key Market Challenges & Risks of Hyperimmune Globulin Product
 Table 58. Key Industry Trends of Hyperimmune Globulin Product
 Table 59. Hyperimmune Globulin Product Raw Material
 Table 60. Key Suppliers of Raw Materials
 Table 61. Hyperimmune Globulin Product Distributors List
 Table 62. Hyperimmune Globulin Product Customer List
 Table 63. Global Hyperimmune Globulin Product Sales Forecast by Region (2026-2031) & (K Units)
 Table 64. Global Hyperimmune Globulin Product Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 65. Americas Hyperimmune Globulin Product Sales Forecast by Country (2026-2031) & (K Units)
 Table 66. Americas Hyperimmune Globulin Product Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 67. APAC Hyperimmune Globulin Product Sales Forecast by Region (2026-2031) & (K Units)
 Table 68. APAC Hyperimmune Globulin Product Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 69. Europe Hyperimmune Globulin Product Sales Forecast by Country (2026-2031) & (K Units)
 Table 70. Europe Hyperimmune Globulin Product Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 71. Middle East & Africa Hyperimmune Globulin Product Sales Forecast by Country (2026-2031) & (K Units)
 Table 72. Middle East & Africa Hyperimmune Globulin Product Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 73. Global Hyperimmune Globulin Product Sales Forecast by Type (2026-2031) & (K Units)
 Table 74. Global Hyperimmune Globulin Product Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 75. Global Hyperimmune Globulin Product Sales Forecast by Application (2026-2031) & (K Units)
 Table 76. Global Hyperimmune Globulin Product Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 77. CSL Behring Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 78. CSL Behring Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 79. CSL Behring Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. CSL Behring Main Business
 Table 81. CSL Behring Latest Developments
 Table 82. Grifols Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 83. Grifols Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 84. Grifols Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Grifols Main Business
 Table 86. Grifols Latest Developments
 Table 87. Biotest Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 88. Biotest Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 89. Biotest Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Biotest Main Business
 Table 91. Biotest Latest Developments
 Table 92. Kedrion Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 93. Kedrion Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 94. Kedrion Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Kedrion Main Business
 Table 96. Kedrion Latest Developments
 Table 97. Emergent Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 98. Emergent Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 99. Emergent Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Emergent Main Business
 Table 101. Emergent Latest Developments
 Table 102. Kamada Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 103. Kamada Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 104. Kamada Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Kamada Main Business
 Table 106. Kamada Latest Developments
 Table 107. CNBG Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 108. CNBG Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 109. CNBG Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. CNBG Main Business
 Table 111. CNBG Latest Developments
 Table 112. Hualan Bio Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 113. Hualan Bio Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 114. Hualan Bio Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Hualan Bio Main Business
 Table 116. Hualan Bio Latest Developments
 Table 117. Shanghai RAAS Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 118. Shanghai RAAS Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 119. Shanghai RAAS Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Shanghai RAAS Main Business
 Table 121. Shanghai RAAS Latest Developments
 Table 122. CBPO Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 123. CBPO Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 124. CBPO Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. CBPO Main Business
 Table 126. CBPO Latest Developments
 Table 127. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 128. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 129. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. Sichuan Yuanda Shuyang Main Business
 Table 131. Sichuan Yuanda Shuyang Latest Developments
 Table 132. ADMA Biologics Basic Information, Hyperimmune Globulin Product Manufacturing Base, Sales Area and Its Competitors
 Table 133. ADMA Biologics Hyperimmune Globulin Product Product Portfolios and Specifications
 Table 134. ADMA Biologics Hyperimmune Globulin Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. ADMA Biologics Main Business
 Table 136. ADMA Biologics Latest Developments


List of Figures
 Figure 1. Picture of Hyperimmune Globulin Product
 Figure 2. Hyperimmune Globulin Product Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Hyperimmune Globulin Product Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Hyperimmune Globulin Product Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Hyperimmune Globulin Product Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Hyperimmune Globulin Product Sales Market Share by Country/Region (2024)
 Figure 10. Hyperimmune Globulin Product Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Hepatitis B Immuneglobulins
 Figure 12. Product Picture of Rabies Immuneglobulins
 Figure 13. Product Picture of Tetanus Toxin Immuneglobulins
 Figure 14. Product Picture of Rho(D) Immune Globulin
 Figure 15. Product Picture of Cytomegalovirus Immune Globulin
 Figure 16. Product Picture of Varicella-Zoster Immune Globulin
 Figure 17. Product Picture of Others
 Figure 18. Global Hyperimmune Globulin Product Sales Market Share by Type in 2025
 Figure 19. Global Hyperimmune Globulin Product Revenue Market Share by Type (2020-2025)
 Figure 20. Hyperimmune Globulin Product Consumed in Government Institution
 Figure 21. Global Hyperimmune Globulin Product Market: Government Institution (2020-2025) & (K Units)
 Figure 22. Hyperimmune Globulin Product Consumed in Private Sector
 Figure 23. Global Hyperimmune Globulin Product Market: Private Sector (2020-2025) & (K Units)
 Figure 24. Hyperimmune Globulin Product Consumed in Others
 Figure 25. Global Hyperimmune Globulin Product Market: Others (2020-2025) & (K Units)
 Figure 26. Global Hyperimmune Globulin Product Sale Market Share by Application (2024)
 Figure 27. Global Hyperimmune Globulin Product Revenue Market Share by Application in 2025
 Figure 28. Hyperimmune Globulin Product Sales by Company in 2025 (K Units)
 Figure 29. Global Hyperimmune Globulin Product Sales Market Share by Company in 2025
 Figure 30. Hyperimmune Globulin Product Revenue by Company in 2025 ($ millions)
 Figure 31. Global Hyperimmune Globulin Product Revenue Market Share by Company in 2025
 Figure 32. Global Hyperimmune Globulin Product Sales Market Share by Geographic Region (2020-2025)
 Figure 33. Global Hyperimmune Globulin Product Revenue Market Share by Geographic Region in 2025
 Figure 34. Americas Hyperimmune Globulin Product Sales 2020-2025 (K Units)
 Figure 35. Americas Hyperimmune Globulin Product Revenue 2020-2025 ($ millions)
 Figure 36. APAC Hyperimmune Globulin Product Sales 2020-2025 (K Units)
 Figure 37. APAC Hyperimmune Globulin Product Revenue 2020-2025 ($ millions)
 Figure 38. Europe Hyperimmune Globulin Product Sales 2020-2025 (K Units)
 Figure 39. Europe Hyperimmune Globulin Product Revenue 2020-2025 ($ millions)
 Figure 40. Middle East & Africa Hyperimmune Globulin Product Sales 2020-2025 (K Units)
 Figure 41. Middle East & Africa Hyperimmune Globulin Product Revenue 2020-2025 ($ millions)
 Figure 42. Americas Hyperimmune Globulin Product Sales Market Share by Country in 2025
 Figure 43. Americas Hyperimmune Globulin Product Revenue Market Share by Country (2020-2025)
 Figure 44. Americas Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
 Figure 45. Americas Hyperimmune Globulin Product Sales Market Share by Application (2020-2025)
 Figure 46. United States Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 47. Canada Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 48. Mexico Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 49. Brazil Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 50. APAC Hyperimmune Globulin Product Sales Market Share by Region in 2025
 Figure 51. APAC Hyperimmune Globulin Product Revenue Market Share by Region (2020-2025)
 Figure 52. APAC Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
 Figure 53. APAC Hyperimmune Globulin Product Sales Market Share by Application (2020-2025)
 Figure 54. China Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 55. Japan Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 56. South Korea Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 57. Southeast Asia Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 58. India Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 59. Australia Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 60. China Taiwan Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 61. Europe Hyperimmune Globulin Product Sales Market Share by Country in 2025
 Figure 62. Europe Hyperimmune Globulin Product Revenue Market Share by Country (2020-2025)
 Figure 63. Europe Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
 Figure 64. Europe Hyperimmune Globulin Product Sales Market Share by Application (2020-2025)
 Figure 65. Germany Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 66. France Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 67. UK Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 68. Italy Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 69. Russia Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 70. Middle East & Africa Hyperimmune Globulin Product Sales Market Share by Country (2020-2025)
 Figure 71. Middle East & Africa Hyperimmune Globulin Product Sales Market Share by Type (2020-2025)
 Figure 72. Middle East & Africa Hyperimmune Globulin Product Sales Market Share by Application (2020-2025)
 Figure 73. Egypt Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 74. South Africa Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 75. Israel Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 76. Turkey Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 77. GCC Countries Hyperimmune Globulin Product Revenue Growth 2020-2025 ($ millions)
 Figure 78. Manufacturing Cost Structure Analysis of Hyperimmune Globulin Product in 2025
 Figure 79. Manufacturing Process Analysis of Hyperimmune Globulin Product
 Figure 80. Industry Chain Structure of Hyperimmune Globulin Product
 Figure 81. Channels of Distribution
 Figure 82. Global Hyperimmune Globulin Product Sales Market Forecast by Region (2026-2031)
 Figure 83. Global Hyperimmune Globulin Product Revenue Market Share Forecast by Region (2026-2031)
 Figure 84. Global Hyperimmune Globulin Product Sales Market Share Forecast by Type (2026-2031)
 Figure 85. Global Hyperimmune Globulin Product Revenue Market Share Forecast by Type (2026-2031)
 Figure 86. Global Hyperimmune Globulin Product Sales Market Share Forecast by Application (2026-2031)
 Figure 87. Global Hyperimmune Globulin Product Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

CSL Behring

Grifols

Biotest

Kedrion

Emergent

Kamada

CNBG

Hualan Bio

Shanghai RAAS

CBPO

Sichuan Yuanda Shuyang

ADMA Biologics

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff